The cumulative incidence of gemcitabine-induced thrombotic microangiopathy.
Arnadottir
Margret
M
Benediktsson
Thorir
T
Hrafnkelsson
Jon
J
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007055:Iceland / Q000453:epidemiology; D015994:Incidence; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D016491:Peripheral Vascular Diseases / Q000139:chemically induced* / Q000453:epidemiology*; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000453:epidemiology*; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine